T2 Biosystems Ownership | Who Owns T2 Biosystems?
T2 Biosystems Ownership Summary
T2 Biosystems is owned by 2.34% institutional investors, and 97.66% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.89% of its assets in T2 Biosystems shares.
TTOO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | T2 Biosystems | 2.34% | - | 97.66% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Diagnostics & Research Stocks | 52.07% | 8.42% | 39.50% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 2 | -96.55% | 119,501 | -99.51% | 2 | 3.52% | - | -100.00% | - | -100.00% |
| Sep 30, 2022 | 58 | -3.33% | 24,520,955 | 29.96% | 8 | 7.16% | 19 | 46.15% | 5 | -61.54% |
| Jun 30, 2022 | 60 | -24.05% | 18,868,777 | 23.98% | 10 | 13.29% | 13 | -31.58% | 13 | -31.58% |
| Mar 31, 2022 | 79 | -7.06% | 15,219,755 | -20.45% | 8 | 6.76% | 19 | -34.48% | 19 | - |
| Dec 31, 2021 | 85 | -1.16% | 19,133,198 | -16.79% | 11 | 5.99% | 29 | 3.57% | 19 | -5.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 154.81K | 0.89% | - |
| BlackRock Extended Equity Market K | 41.10K | 0.24% | -17.00 |
| Fidelity Extended Market Index | 37.74K | 0.22% | -52.74K |
| Vanguard Institutional Extnd Mkt Idx Tr | 30.86K | 0.16% | -198.28K |
| Fidelity Total Market Index | 21.41K | 0.12% | - |
| NT Ext Equity Mkt Idx Fd - L | 16.11K | 0.09% | - |
| Northern Trust Extended Eq Market Idx | 16.11K | 0.09% | - |
| NT Ext Equity Mkt Idx Fd - NL | 10.63K | 0.06% | -11.13K |
| Fidelity Nasdaq Composite Index | 9.34K | 0.05% | - |
| Spartan Total Market Index Pool E | 8.83K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 13, 2024 | Elsbree David B | - | Sell | $133.10 |
| Feb 20, 2023 | Giffin Brett A. | Chief Commercial Officer | Sell | $349.05 |
| Sep 27, 2023 | CR Group L.P. | - | Sell | $310.64K |
| Sep 27, 2023 | CR Group L.P. | - | Sell | $285.39K |
| Sep 27, 2023 | CR Group L.P. | - | Sell | $458.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | - | 29 |
| 2023 Q1 | - | 9 |
| 2022 Q4 | - | 1 |
TTOO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools